Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy
European Journal of Neurology, 11/02/09
Modrego PJ et al. – Donepezil and memantine have similar modest clinical and spectroscopic effect on mild to moderate AD. MRS could be useful to monitor progression of the disease.
Related Articles
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09
Relevance Score: 81%
Benefit Of Memantine In The Treatment Of Alzheimers Disease Not Proven
ScienceDaily, 10/29/09
Relevance Score: 81%
Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09
Relevance Score: 71%
High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09
Relevance Score: 70%
Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09
Relevance Score: 69%
Today in Neuroradiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diffusion-Weighted Imaging Predicts Cognition in Pediatric Brain Injury
Pediatric Neurology , 11/21/09
Cerebral and cerebellar white matter abnormalities with magnetic resonance imaging in a child with Feingold syndrome
American Journal of Medical Genetics, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


